Novi, MI, United States of America

Eshwar Inapuri

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Innamed, Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eshwar Inapuri: Innovator in Lipoprotein Detection

Introduction

Eshwar Inapuri is a notable inventor based in Novi, MI (US). He has made significant contributions to the field of biochemistry, particularly in the development of aptamers for measuring lipoprotein levels. His work has the potential to impact medical diagnostics and therapeutic applications.

Latest Patents

Eshwar holds a patent for "Aptamers for measuring lipoprotein levels." This patent provides innovative aptamers designed for binding lipoproteins, along with systems and methods for detecting lipoproteins in biological samples. The aptamers are particularly useful for selectively detecting LDL particles in the presence of HDL particles. Furthermore, these aptamers can serve as therapeutic agents against various diseases, showcasing their versatility and importance in healthcare.

Career Highlights

Eshwar Inapuri is currently associated with Innamed, Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the application of his patented technologies in real-world medical scenarios.

Collaborations

Eshwar collaborates with talented individuals such as Anup Singh and Gregory Allen Penner. These partnerships enhance the innovative environment at Innamed, Inc. and contribute to the success of their projects.

Conclusion

Eshwar Inapuri's contributions to the field of lipoprotein detection through his innovative aptamers represent a significant advancement in medical diagnostics. His work not only highlights his expertise but also the collaborative spirit within the research community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…